{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:35:43Z","timestamp":1777502143091,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ccl.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T10:35:07Z","timestamp":1540809307000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arrhythmia Evaluation and Management"],"prefix":"10.1016","volume":"37","author":[{"given":"Jason T.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ccl.2018.08.005_bib1","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.ccl.2018.08.005_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2018.08.005_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ejcts\/ezs332","article-title":"A\u00a0retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China","volume":"43","author":"Wang","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"10.1016\/j.ccl.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2004.09.036","article-title":"Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue","volume":"44","author":"Talreja","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jcin.2015.11.036","article-title":"Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly","volume":"9","author":"Liebregts","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.ccl.2018.08.005_bib6","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2007.02.056","article-title":"Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Lawrenz","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0735-1097(03)00623-5","article-title":"Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy","volume":"42","author":"Chang","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1540-8183.2007.00220.x","article-title":"Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation","volume":"20","author":"El-Jack","year":"2007","journal-title":"J\u00a0Interv Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/joic.12178","article-title":"Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy","volume":"28","author":"Schuller","year":"2015","journal-title":"J\u00a0Interv Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2018.08.005_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A\u00a0systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/01.CIR.90.6.2731","article-title":"Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy","volume":"90","author":"Fananapazir","year":"1994","journal-title":"Circulation"},{"issue":"8805","key":"10.1016\/j.ccl.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0140-6736(92)91961-7","article-title":"Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy","volume":"339","author":"Jeanrenaud","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccl.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","article-title":"Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial","volume":"29","author":"Nishimura","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.75.1.44","article-title":"DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience","volume":"75","author":"Slade","year":"1996","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ccl.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.98.3.242","article-title":"Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease","volume":"98","author":"Pak","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/pace.12016","article-title":"Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy","volume":"36","author":"Yue-Cheng","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.ccl.2018.08.005_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","article-title":"Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group","volume":"18","author":"Kappenberger","year":"1997","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ccl.2018.08.005_bib18","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"issue":"6\u20137","key":"10.1016\/j.ccl.2018.08.005_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.acvd.2013.04.003","article-title":"Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy","volume":"106","author":"Lucon","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.recesp.2015.08.022","article-title":"Sequential atrioventricular pacing in patients with hypertrophic cardiomyopathy: an 18-year experience","volume":"69","author":"Jurado Rom\u00e1n","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.005_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.hrthm.2015.01.032","article-title":"Optimized pacing mode for hypertrophic cardiomyopathy: impact of ECG fusion during pacing","volume":"12","author":"Berruezo","year":"2015","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ccl.2018.08.005_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.hrthm.2010.10.010","article-title":"Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study","volume":"8","author":"Berruezo","year":"2011","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/europace\/euw327","article-title":"Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy","volume":"20","author":"Killu","year":"2018","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","article-title":"Adenosine monophosphate-activated protein kinase disease mimics hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history","volume":"45","author":"Murphy","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ccl.2018.08.005_bib27","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccl.2018.08.005_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.amjcard.2017.02.040","article-title":"Occurrence and natural history of clinically silent episodes of atrial fibrillation in hypertrophic cardiomyopathy","volume":"119","author":"Rowin","year":"2017","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cdt.2016.11.23","article-title":"Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis","volume":"7","author":"Masri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy","volume":"119","author":"van Velzen","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial\u00a0fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib32","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jtcvs.2017.08.063","article-title":"Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy","volume":"155","author":"Bogachev-Prokophiev","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCEP.109.871665","article-title":"Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis","volume":"2","author":"Perez","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/europace\/euv339","article-title":"Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"18","author":"Zhao","year":"2016","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ccl.2018.08.005_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2008.01192.x","article-title":"Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"19","author":"Bunch","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.ccl.2018.08.005_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of\u00a0catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.ccl.2018.08.005_bib37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/heartjnl-2016-309406","article-title":"Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"102","author":"Providencia","year":"2016","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccl.2018.08.005_bib39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1540-8167.2010.01769.x","article-title":"Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy","volume":"21","author":"Furushima","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.005_bib40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/europace\/eur344","article-title":"Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy","volume":"14","author":"Ueda","year":"2012","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.CIR.59.4.689","article-title":"Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy","volume":"59","author":"Maron","year":"1979","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2018.08.005_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.76.5.412","article-title":"Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy","volume":"76","author":"Sepp","year":"1996","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ccl.2018.08.005_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","article-title":"Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy","volume":"88","author":"Varnava","year":"2001","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ccl.2018.08.005_bib45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2018.08.005_bib46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10554-008-9292-6","article-title":"Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study","volume":"24","author":"Kwon","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ccl.2018.08.005_bib47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1540-8167.1997.tb00838.x","article-title":"Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy","volume":"8","author":"Rodriguez","year":"1997","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.ccl.2018.08.005_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1540-8167.2008.01366.x","article-title":"Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm","volume":"20","author":"Lim","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1540-8167.2010.01875.x","article-title":"Substrate characterization and catheter ablation for\u00a0monomorphic ventricular tachycardia in patients\u00a0with apical hypertrophic cardiomyopathy","volume":"22","author":"Inada","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.ccl.2018.08.005_bib50","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.hrthm.2010.05.022","article-title":"Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility","volume":"7","author":"Santangeli","year":"2010","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ccl.2018.08.005_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","article-title":"Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy","volume":"4","author":"Dukkipati","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccl.2018.08.005_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jce.12547","article-title":"Mapping and ablating ventricular premature contractions that trigger ventricular fibrillation: trigger elimination and substrate modification","volume":"26","author":"Nogami","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865118308646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865118308646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:21Z","timestamp":1760007081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865118308646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0733865118308646"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2018.08.005","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arrhythmia Evaluation and Management","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}